Welcome to iDSI, the international Decision Support Initiative. We provide a platform for supporting low and middle income country (LMIC) policymakers in making better use of healthcare resources to generate maximum health, in their journeys towards universal health coverage (UHC).

Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B

With Universal Health Coverage (UHC) high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in the scale-up of essential health services to meet the needs of their people. This has led to the recognition of health te

Natthida Malathong received Bachelor’s in Public Health form major of Public Health, School of Health Science, Mae Fah Luang University in 2015. She start working in HITAP’s research assistant sine 2015 to May 2019 and currently working as a Operations Management Associate

Naiyana Praditsitthikorn BSc(Pharm), PhD*,** * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand ** Bureau of AIDS TB and STIs, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand There is an increasing number of at

This year’s conference was held at La Than Hotel in Hanoi, Vietnam from 17th to 19th April 2017 organized by Health Strategy and Planning Institute (HSPI), Ministry of Health, Vietnam. Around 120 participants attended the conference. The theme this year was ‘Health Technology Assessment in designing

ID modelling is a mathematical description of the spread of infection (1). Infectious disease (ID) in this study refers to common infectious diseases (whether in humans or animals), including COVID-19. ID models help provide the understanding of the disease natural history, as well as the impact of interventions (e.g., vaccination, social distancin

This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under

K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand

Abstract Background The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance struct